Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...
KTM 890 Duke over Kawasaki Ninja ZX-10R in a survey being conducted on zigwheels.com. Apart from this survey a total of 413 users have also rated KTM 890 Duke and Kawasaki Ninja ZX-10R on some really ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback